Drawing for ELEVATING THE ESSENTIALS

USPTO serial 79455873

ELEVATING THE ESSENTIALS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SEVERSON, JUSTIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with ELEVATING THE ESSENTIALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflux, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; pharmaceutical preparations for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflux, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, diuretic agents, psychiatrics, antivirals, thyroid agents, corticosteroids, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents.ACTIVE—
035Outsourcing services in the nature of arranging procurement of goods for others in the field of pharmaceuticals; business administration of patient reimbursement programs for pharmaceuticals; business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient.ACTIVE—
040Custom manufacture of pharmaceutical products to the order and specification of others; providing technical information in the field of pharmaceutical manufacturing.ACTIVE—
042Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services.ACTIVE—
044Charitable services, namely patient assistance programs that provide pharmaceuticals to help patients with low income get pharmaceuticals at little or no cost to the patient.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (PUBO): Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.

DateCodeEventWhat it means
Nov 17, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 11, 2026NPUBNOTICE OF PUBLICATION—
Oct 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2026DOCKASSIGNED TO EXAMINER—
Aug 10, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 6, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance